MedPath

The effects of Geotherapy on Heartburn and Reflux Symptoms: pilot clinical trial

Phase 1
Conditions
heartburn, peptic esophagiti
C23.888.821.525
C06.405.117.620.420
Registration Number
RBR-44np8k
Lead Sponsor
nisul
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Be at least 21 years of age;
Have a diagnosis of gastroesophageal reflux;
Be willing to attend the sessions of the research protocol in full;
Know how to read and write;

Exclusion Criteria

Present lesions on the skin in the region where the clay poultice will be applied;
Patients undergoing recent gastroesophageal surgery (time less than 30 days), who present a surgical incision in the healing process and still under the effect of post-surgical drug therapy (analgesics, antipyretic and antiemetic);
Use of topical medications in the region that compromise the application of epigastric cataplasm.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate improvement in pain relief and symptom relief in gastroesophageal reflux disease with yellow clay epigastric cataplasm.<br>
Secondary Outcome Measures
NameTimeMethod
Decreased pain and symptoms in GERD with application of epigastric yellow clay cataplasm. It was evaluated by three questionnaires (QS-GERD, EVA and Sociodemographic)<br>Data collected during the intervention and after one month of the intervention.<br>The p-value relative to the first and the sixth version of the poultice program was 0.002 and the p-value relative to a first alation before the poultice in relation to a sixth posterior application of the poultice was 0.001
© Copyright 2025. All Rights Reserved by MedPath